Use of continuous glucose monitoring in children and adolescents (*).

Moshe Phillipa,b,c, Thomas Danned, Shlomit Shalitina,b,c, Bruce Buckinghame, Lori Laffelf, William Tamborlaneg, Tadej Battelinoh and for the Consensus Forum Participantsi aThe Jesse Z and Sara Lea Shafer Institute of Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children’s Medical Center of Israel, Petach Tikva, Israel; bMolecular Endocrinology and Diabetes Laboratory, Felsenstein Medical Research Center, Petah Tikva, Israel; cSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; dDiabetes Zentrum fur Kinder und Jugendliche, Kinderkrankenhaus auf der Bult, Hannover, Germany; ePediatric Endocrinology, Stanford University, Stanford, CA, USA; fPediatric, Adolescent and Young Adult Section, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA; gPediatric Endocrinology, Yale University School of Medicine, New Haven, CT, USA; hDepartment of Pediatric Endocrinology, Diabetes Metabolism, University Children’s Hospital, Ljubljana, Slovenia and iA complete list of participants in the forum can be found in the acknowledgments.